A pairing appears on this page only when a trial gave both ingredients together and measured the result. Jerusalem Artichoke has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
Jerusalem artichoke tuber stores its carbohydrate as inulin-type fructans rather than starch. Combining tuber powder with isolated inulin stacks the same fermentable substrate, so the fibre dose adds rather than doing anything new. Formulators watching total fructan load should count both. Gas and bloating scale with the combined amount, not with either source alone.
Bifidobacteria possess fructan-degrading enzymes that most gut genera lack, which is why inulin-type fibre selectively feeds them. Pairing the tuber fibre with a bifidobacterial strain supplies substrate alongside the organism. This is a substrate-and-organism pairing, not evidence that any particular strain persists. Colonisation is a separate question from fermentation.
Some lactobacilli can use fructo-oligosaccharide fractions of inulin, though chain length matters and long-chain inulin is used less readily than short-chain material. The pairing is standard synbiotic practice. Read it as formulation logic backed by fermentation chemistry rather than as a demonstrated clinical outcome.
Bifidobacteria ferment fructans to acetate and lactate, which butyrate-producing Firmicutes then convert onward. That cross-feeding chain is why a fibre with no butyrate in it raises colonic butyrate. Supplying butyrate directly bypasses the fermentation step and mostly acts in the upper colon unless it is coated. The two routes are different in where they deliver.
Short-chain fatty acids generated from fructan fermentation acidify the colonic lumen and keep calcium in solution past the point where it would otherwise precipitate. Human balance studies with inulin-type fructans report increased fractional calcium absorption, mostly in adolescents. This is an absorption marker, and downstream bone effects are a separate and less settled question.
Fructan fermentation lowers luminal pH and enlarges the pool of soluble divalent cations reaching the colonic mucosa. Magnesium absorption gains reported with inulin-type fibre are smaller and less consistent than the calcium findings. Regard it as a plausible secondary effect rather than a reliable one.
Iron is absorbed mainly in the duodenum, upstream of where fructans ferment, so a direct competition mechanism is weak. What is reported is an indirect effect through colonic pH and microbiota composition, with mixed direction across studies. Nothing here supports a firm rule about spacing the two apart.
Psyllium forms a gel and passes the colon substantially intact, so it adds bulk and slows transit without generating much gas. Jerusalem artichoke fructans are fermented briskly and generate gas but little viscosity. Combining them covers two different fibre functions. It also means total tolerability is driven mainly by the fructan side.
Resistant starch ferments more distally and skews toward butyrate, while inulin-type fructans ferment proximally and skew toward acetate. Used together the fermentation is spread across more of the colon. The trade-off is a higher combined fermentable load, so gas is additive too.
Pancreatic amylase cleaves alpha-glucosidic bonds and does nothing to the beta(2-1) linkages in inulin. Standard digestive enzyme blends therefore do not reduce fructan fermentation or the gas that comes with it. A dedicated fructan-hydrolysing enzyme preparation is a different product class. Ordinary enzyme complexes are not a workaround for fructan intolerance.
Nothing specific on file for Jerusalem Artichoke. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.These are the studies our verdict leans on, chosen from the 7 we read for Jerusalem Artichoke. The full linked list is below.
2 sources behind our Jerusalem Artichoke verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.